v3.26.3
Consolidated Statements Of Cash Flows
$ in Thousands
 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Net income $ 229,897 $ 208,032  
Gain on real estate transactions (31,666) (34,236)  
Deferred income tax expense (benefit) 515 (676)  
Financing Receivable, Credit Loss, Expense (Reversal) (4,623) 9,462  
Write off of Deferred Debt Issuance Cost 605 0  
Equity in loss from joint ventures (1,061) (1,394)  
Proceeds from Equity Method Investment, Distribution 7 11  
Depreciation and amortization 144,667 125,578  
Amortization of deferred financing costs 8,471 6,428  
Amortization of above/below market leases and tenant allowances, net 11 (243)  
Share-based Payment Arrangement, Noncash Expense 13,324 11,686  
share based compensation included in severance expense 1,041 847  
Increase (Decrease) in Operating Lease Assets and Liabilities, Net (1,380) (1,048)  
Mortgage notes accrued interest receivable (1,866) (2,245)  
Accounts receivable (9,361) (10,272)  
Other assets (1,258) (3,559)  
Accounts payable and accrued liabilities 17,964 9,528  
Increase (Decrease) in Deferred Revenue 8,110 2,486  
Net cash provided by operating activities 375,519 323,173  
Investing activities:      
Payments to Acquire Productive Assets 562,838 23,914  
Proceeds from Sale of Productive Assets 68,878 125,697  
Payments to Acquire Interest in Subsidiaries and Affiliates 0 (1,432)  
Payments for Derivative Instrument, Investing Activities (2,876) 0  
Investment in mortgage notes receivable (41,908) (48,073)  
Proceeds from Sale and Collection of Mortgage Notes Receivable 14,761 9,633  
Proceeds from promissory note receivable paydown 3,513 1,259  
Additions to properties under development (61,269) (69,676)  
Net cash used by investing activities (581,739) (6,506)  
Financing activities:      
Proceeds from long-term debt facilities 1,403,000 484,000  
Repayments of Long-Term Debt (982,597) (580,000)  
Deferred financing fees paid (14,639) (446)  
Net proceeds from issuance of common shares 664 709  
Payment, Tax Withholding, Share-based Payment Arrangement 0 (1)  
Purchase of common shares for treasury (13,143) (9,833)  
Dividends paid to shareholders (227,750) (217,393)  
Net cash provided (used) by financing activities 165,535 (322,964)  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (686) 290  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (41,371) (6,007)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57,277 29,692 $ 35,699
Cash and Cash Equivalent 52,354 13,710 22,062
Restricted Cash and Cash Equivalent 4,923 15,982 $ 13,637
Supplemental schedule of non-cash activity:      
Transfer of property under development to rental property 55,538 98,956  
Non-cash Conversion of Mortgage Note Receivable to Real Estate 72,800 0  
Issuance of nonvested shares and restricted share units at fair value, including nonvested shares issued for payment of bonuses 29,221 29,719  
Remeasurement of right-of-use asset from early ground lease termination 0 7,439  
Remeasurement of lease liability from early ground lease termination 0 10,901  
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 53,174 0  
Operating Lease, Cost 53,174 0  
Supplemental disclosure of cash flow information:      
Interest Paid, Excluding Capitalized Interest, Operating Activity 87,586 88,067  
Cash paid during the period for income taxes 3,094 2,329  
Interest cost capitalized 740 3,154  
Change in accrued capital expenditures $ (7,342) $ (3,736)